Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

9773	Companies
195568	Keywords
126553	Articles
103965	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 04/04/2025 at 00:05, 9 months 26 days ago

Inka Health's Analytical Achievements for AstraZeneca Canada Highlighted at ISPOR 2025

Real-world Evidence Pharmaceutical Analytics ISPOR 2025 Healthcare Decision-Making AstraZeneca Collaboration
PRESS RELEASE

published on 04/04/2025 at 00:00, 9 months 26 days ago

Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
Onco-Innovations Limited's subsidiary, Inka Health Corp., completes analytical work for AstraZeneca Canada, showcasing advancements in pharmaceutical evidence generation and real-world data use

Real-world Data Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Pharmaceutical Evidence Generation
BRIEF

published on 03/26/2025 at 23:05, 10 months 3 days ago

Study Explores Low Toxicity of Onco-Innovations' PNKP Technology

Cancer Treatment Radiation Therapy Onco-Innovations PNKP Technology Low Toxicity
PRESS RELEASE

published on 03/26/2025 at 23:00, 10 months 3 days ago

Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile
Onco-Innovations Limited announces successful nanoparticle formulation of PNKP Compound with low toxicity and effective cancer cell targeting in mice, promising safer treatment options

Cancer Treatment Onco-Innovations Limited Nanoparticle Formulation PNKP Compound Low Toxicity
BRIEF

published on 03/25/2025 at 22:05, 10 months 4 days ago

Onco-Innovations Extends Marketing Partnership with MCS

Digital Advertising Onco-Innovations Marketing Extension MCS Partnership CAD 600,000 Budget
PRESS RELEASE

published on 03/25/2025 at 22:00, 10 months 4 days ago

Onco-Innovations Extends Marketing Program
Onco-Innovations Limited extends engagement with MCS Market Communication Service GmbH for online marketing services until May 31, 2025. Company aims to revolutionize cancer treatment with patented technology

Patented Technology Cancer Treatment Onco-Innovations Limited MCS Market Communication Service GmbH Online Marketing Services
BRIEF

published on 03/24/2025 at 23:05, 10 months 5 days ago

Onco-Innovations Updates Proceeds Utilization Strategy

Investor Relations Equity Financing Research And Development Onco-Innovations Proceeds Update
PRESS RELEASE

published on 03/24/2025 at 23:00, 10 months 5 days ago

Onco-Innovations Provides Update on Use of Proceeds
Onco-Innovations Limited provides an update on the use of proceeds from its Prospectus, focusing on investor relations activities and increased research and development spending for cancer treatments

Investor Relations Research And Development Cancer Treatment Onco-Innovations Limited Use Of Proceeds
BRIEF

published on 03/02/2025 at 21:05, 10 months 27 days ago

Onco-Innovations CEO Discusses Breakthroughs in Cancer Treatment on Popular Program

AI Integration Clinical Trials Cancer Treatment Precision Medicine Global Partnerships
PRESS RELEASE

published on 03/02/2025 at 21:00, 10 months 27 days ago

Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion
Onco-Innovations Limited's CEO, Thomas O'Shaughnessy, featured in an exclusive interview on Conversations That Matter discussing the Company's efforts in developing cancer treatment and strategic partnerships

Clinical Trials Cancer Treatment Precision Medicine Onco-Innovations Limited Thomas O'Shaughnessy

Accesswire

Published on 01/30/2026 at 02:15, 1 hour 23 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 3 hours 38 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 4 hours 38 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 8 hours 53 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 9 hours 38 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 00:07, 3 hours 31 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 6 hours 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 6 hours 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 20:59, 6 hours 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 6 hours 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 01/29/2026 at 18:00, 9 hours 38 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 9 hours 53 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 9 hours 53 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 9 hours 58 minutes ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 17 hours 31 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE